• 한국응용과학기술학회지
• /
• 제40권4호
• /
• pp.685-698
• /
• 2023

본 연구는 한국인 인구집단에서 폭식행동, 음식중독을 식별하고, 해당 증상들이 비만 및 섭식행동, 정신건강, 인지적 특성과 어떠한 연관성을 보이는지 규명하고자 하였다. 이를 위하여 정상체중 및 비만체중에 해당하는 한국인 성인 257명을 대상으로 섭식문제(예: 폭식, 음식중독, 음식갈망), 정신건강(예: 우울), 인지기능(예: 충동성, 정서조절)에 관한 임상심리검사 척도를 측정하였다. 비만 여부와 성별에 따라 그룹을 나누었을 때, 비만체중 여성에서 폭식행동이 46.6%, 음식중독이 29.3%로 가장 빈도가 높았다. 성향점수 매칭 후 데이터로 독립성 검정을 수행한 결과, 폭식행동 및 음식중독이 비만체중 집단에서 정상체중 집단보다 더 많이 나타나는 것을 확인하였다. 또한 폭식행동과 음식중독 유무에 각 심리검사 척도 요인이 미치는 영향력을 파악하고자, 전진선택법을 적용한 로지스틱 회귀모델을 구축하였다. 로지스틱 회귀분석 결과, 폭식행동에는 섭식장애, 음식갈망, 상태불안, 정서조절(인지적 재해석) 및 음식중독이 주로 관여하였고, 음식중독에는 음식갈망, 폭식행동과 함께 비만과 연령의 교호작용, 교육년수가 유의하게 작용하는 것으로 나타났다. 본 연구는 한국인 성인을 대상으로 한 체계적 연구로서, 폭식행동과 음식중독이 여성 및 비만인에서 특히 더 많이 나타남을 확인하였다. 폭식행동과 음식중독에는 일부 섭식문제(예: 음식갈망)가 공통되게 관여하나, 정신건강 및 인지적 위험요인에는 차이가 있었다. 따라서 음식중독과 폭식행동은 서로 구별되는 개념으로 두고, 각각의 기질적·환경적 위험요인을 깊이 있게 탐구하는 것이 필요하다.

• Journal of Gastric Cancer
• /
• 제18권3호
• /
• pp.230-241
• /
• 2018

Purpose: Enhanced recovery after surgery (ERAS) protocols for gastric cancer patients have shown improved outcomes in Asia. However, data on gastric cancer ERAS (GCERAS) programs in the United States are sparse. The purpose of this study was to compare perioperative outcomes before and after implementation of an GC-ERAS protocol at a National Comprehensive Cancer Center in the United States. Materials and Methods: We reviewed medical records of patients surgically treated for gastric cancer with curative intent from January 2012 to October 2016 and compared the GC-ERAS group (November 1, 2015-October 1, 2016) with the historical control (HC) group (January 1, 2012-October 31, 2015). Propensity score matching was used to adjust for age, sex, number of comorbidities, body mass index, stage of disease, and distal versus total gastrectomy. Results: Of a total of 95 identified patients, matching analysis resulted in 20 and 40 patients in the GC-ERAS and HC groups, respectively. Lower rates of nasogastric tube (35% vs. 100%, P<0.001) and intraabdominal drain placement (25% vs. 85%, P<0.001), faster advancement of diet (P<0.001), and shorter length of hospital stay (5.5 vs. 7.8 days, P=0.01) were observed in the GC-ERAS group than in the HC group. The GC-ERAS group showed a trend toward increased use of minimally invasive surgery (P=0.06). There were similar complication and 30-day readmission rates between the two groups (P=0.57 and P=0.66, respectively). Conclusions: The implementation of a GC-ERAS protocol significantly improved perioperative outcomes in a western cancer center. This finding warrants further prospective investigation.

• 대한치과보철학회지
• /
• 제58권3호
• /
• pp.193-200
• /
• 2020

목적: 대규모 인구집단데이터를 사용하여 양측 또는 편측 완전 무치악 여부와 치매와의 관련성에 대하여 알아본다. 재료 및 방법: 만 60세 이상을 대상으로 구축된 건강보험공단 노인 코호트 데이터베이스를 사용하여 후향적 코호트 연구를 설계하였다. 실험군은 완전 무치악 코호트로 2012년 7월 1일부터 2013년 12월 31일 까지 1개 이상의 상악 또는 하악 레진상 완전의치 보험 처방 이력이 있는 사람을 대상으로 하였고, 대조군은 유치악 코호트로 같은 기간 동안 잔존치아에 대한 보존적 치아 처치 이력이 있는 사람을 대상으로 하였다. 모든 대상자들은 이 기간 동안 치매로 진단 또는 치료 받은 기록이 없었다. 성향점수매칭법에 따라 연령과 성별, 그리고 거주지역을 고려하여 실험군과 대조군을 1:1 동수로 매칭하였고, 두 코호트 집단간 2년 동안 치매로 이환된 비율을 비교하였다. 결과: 실험군과 대조군을 비교했을 때, 실험군인 양측 또는 편측 완전 무치악 환자에서 치매 발병률(12.13%)은 대조군인 유치악 환자의 치매 발병률(9.74%) 보다 유의미하게 높다는 것을 확인할 수 있었다 (P < .05). 다른 요인들과 치매와의 명확한 관련성은 확인되지 않았다. 결론: 대규모 인구집단데이터 분석을 통해 양측 또는 편측 완전 무치악 환자에서 치매 발병률이 높다는 것을 확인할 수 있었다.

• Journal of Gastric Cancer
• /
• 제23권3호
• /
• pp.499-508
• /
• 2023

Purpose: Despite scientific evidence regarding laparoscopic gastrectomy (LG) for advanced gastric cancer treatment, its application in patients receiving neoadjuvant chemotherapy remains uncertain. Materials and Methods: We used the 2019 Korean Gastric Cancer Association nationwide survey database to extract data from 489 patients with primary gastric cancer who received neoadjuvant chemotherapy. After propensity score matching analysis, we compared the surgical outcomes of 97 patients who underwent LG and 97 patients who underwent open gastrectomy (OG). We investigated the risk factors for postoperative complications using multivariate analysis. Results: The operative time was significantly shorter in the OG group. Patients in the LG group had significantly less blood loss than those in the OG group. Hospital stay and overall postoperative complications were similar between the two groups. The incidence of Clavien-Dindo grade ≥3 complications in the LG group was comparable with that in the OG group (1.03% vs. 4.12%, P=0.215). No statistically significant difference was observed in the number of harvested lymph nodes between the two groups (38.60 vs. 35.79, P=0.182). Multivariate analysis identified body mass index (odds ratio [OR], 1.824; 95% confidence interval [CI], 1.029-3.234; P=0.040) and extent of resection (OR, 3.154; 95% CI, 1.084-9.174; P=0.035) as independent risk factors for overall postoperative complications. Conclusions: Using a large nationwide multicenter survey database, we demonstrated that LG and OG had comparable short-term outcomes in patients with gastric cancer who received neoadjuvant chemotherapy.

• 벤처창업연구
• /
• 제18권1호
• /
• pp.225-236
• /
• 2023

2015년~2021년 혁신인증을 획득한 혁신형 중소기업과 일반 중소기업에 대해 생존기간의 관점에서 비교·분석하여 정책적 시사점을 도출하였다. 업력, 규모(고용인원, 자본 및 부채, 매출액 및 영업이익), 한국표준산업분류 중분류를 이용하여 혁신형 중소기업과 유사한 일반 중소기업을 선별하였으며, 생존기간은 휴·폐업 및 부도에 준하는 연체를 사건으로 정의하여 산출하였다. 생존분석 결과 혁신형 중소기업은 일반 중소기업 대비 휴·폐업 및 연체 발생 위험이 9.8% 감소하는 것으로 나타나, 혁신형 중소기업의 생존기간이 유의하게 길다는 결론을 도출하였다. 그 외 중소기업의 업력과 규모(고용인원, 자본)는 생존기간에 정(+)의 영향을, 부채는 부(-)의 영향을 미치는 것으로 나타났다. 따라서 혁신역량과 미래성장성 중심의 혁신인증 제도는 생존기간의 관점에서 유의한 지표이며, 혁신인증 제도의 혜택 및 지원정책이 중소기업의 실질적 성장과 생존을 위해서는 업력 및 업종을 반영하여 보다 체계적이고 정교화 될 필요가 있다는 결론을 도출하였다.

• 보건행정학회지
• /
• 제30권2호
• /
• pp.185-191
• /
• 2020

Background: From January 2018, a policy was applied to differentially apply the co-payment for medical expenses of 15,000 won or more from 30% to 10%-30% for each medical fee. This policy lowers the burden on the medical use of the elderly, and it is necessary to analyze the effect of the policy by confirming changes in medical use and supply behavior after 2 years. Methods: The National Health Insurance Service's national medical use database was used. As for the analysis method, first, the medical use and medical supply behavior change over the age of 65 years were confirmed, and second, in order to check the net effect of the policy, the 66-year-old as the experimental group and the 63-year-old as the control group were selected as the control group. The propensity score matching was performed using the variables of age, living alone, income quartile, residence, disability, chronic disease, and co-morbid disease scores, and then it was analyzed using the difference in difference analysis method. Results: The share of the number of treatments under 15,000 won decreased from 37.0% in 2017 to 20.2% in 2018, while the share of the number of treatments under 15,001-20,000 won increased from 8.0% to 22.7%. It was confirmed that the reason for the increase in the cost of treatment per treatment was the result of the increase in the amount of physical therapy and examination. As a result of the policy effect, the burden of co-payment per person was reduced, and as a result, the number of hospital visits per person and the total medical cost per person increased. Conclusion: The self-pay rate differential policy reduced the burden of medical expenses for the elderly and confirmed the increase in medical use. However, the interpretation of the increase in medical use was not able to distinguish whether the unsatisfactory medical care was satisfied or the inducement demand. Efficient allocation of resources is a more important point in the future when the super-aged society is in front. It is necessary to prepare a plan to induce rational medical use within a range that does not impair the medical accessibility of the elderly.

• Journal of Gastric Cancer
• /
• 제20권2호
• /
• pp.152-164
• /
• 2020

Purpose: To compare long-term disease-free survival (DFS) between patients receiving tegafur/gimeracil/oteracil (S-1) or capecitabine plus oxaliplatin (CAPOX) adjuvant chemotherapy (AC) for gastric cancer (GC). Materials and Methods: This retrospective multicenter observational study enrolled 983 patients who underwent curative gastrectomy with consecutive AC with S-1 or CAPOX for stage II or III GC at 27 hospitals in Korea between February 2012 and December 2013. We conducted propensity score matching to reduce selection bias. Long-term oncologic outcomes, including DFS rate over 5 years (over-5yr DFS), were analyzed postoperatively. Results: The median and longest follow-up period were 59.0 and 87.6 months, respectively. DFS rate did not differ between patients who received S-1 and CAPOX for pathologic stage II (P=0.677) and stage III (P=0.899) GC. Moreover, hazard ratio (HR) for recurrence did not differ significantly between S-1 and CAPOX (reference) in stage II (HR, 1.846; 95% confidence interval [CI], 0.693-4.919; P=0.220) and stage III (HR, 0.942; 95% CI, 0.664-1.337; P=0.738) GC. After adjustment for significance in multivariate analysis, pT (4 vs. 1) (HR, 11.667; 95% CI, 1.595-85.351; P=0.016), pN stage (0 vs. 3) (HR, 2.788; 95% CI, 1.502-5.174; P=0.001), and completion of planned chemotherapy (HR, 2.213; 95% CI, 1.618-3.028; P<0.001) were determined as independent prognostic factors for DFS. Conclusions: S-1 and CAPOX AC regimens did not show significant difference in over-5yr DFS after curative gastrectomy in patients with stage II or III GC. The pT, pN stage, and completion of planned chemotherapy were prognostic factors for GC recurrence.

• Journal of Gastric Cancer
• /
• 제18권3호
• /
• pp.264-273
• /
• 2018

Purpose: To investigate the current status of adjuvant chemotherapy (AC) regimens in Korea and the difference in efficacy of AC administered by surgical and medical oncologists in patients with stage II or III gastric cancers. Materials and Methods: We performed a retrospective observational study among 1,049 patients who underwent curative resection and received AC for stage II and III gastric cancers between February 2012 and December 2013 at 29 tertiary referral university hospitals in Korea. To minimize the influence of potential confounders on selection bias, propensity score matching (PSM) was used based on binary logistic regression analysis. The 3-year disease-free survival (DFS) rates were compared between patients who received AC administered by medical oncologists or surgical oncologists. Results: Between February 2012 and December 2013 in Korea, the most commonly prescribed AC by medical oncologists was tegafur/gimeracil/oteracil (S-1, 47.72%), followed by capecitabine with oxaliplatin (XELOX, 16.33%). After performing PSM, surgical oncologists (82.74%) completed AC as planned more often than medical oncologists (75.9%), with statistical significance (P=0.036). No difference in the 3-year DFS rates of stage II (P=0.567) or stage III (P=0.545) gastric cancer was found between the medical and surgical oncologist groups. Conclusions: S-1 monotherapy and XELOX are a main stay of AC, regardless of whether the prescribing physician is a medical or surgical oncologist. The better compliance with AC by surgical oncologists is a valid reason to advocate that surgical oncologists perform the treatment of AC for stage II or III gastric cancers.

• Journal of Chest Surgery
• /
• 제55권1호
• /
• pp.49-54
• /
• 2022

Background: We compared the safety and effectiveness of robotic anatomical resection and video-assisted thoracoscopic surgery (VATS). Methods: A retrospective analysis was conducted of the records of 4,283 patients, in whom an attempt was made to perform minimally invasive anatomical resection for lung cancer at Seoul National University Hospital from January 2011 to July 2020. Of these patients, 138 underwent robotic surgery and 4,145 underwent VATS. Perioperative outcomes were compared after propensity score matching including age, sex, height, weight, pulmonary function, smoking status, performance status, comorbidities, type of resection, combined bronchoplasty/angioplasty, tumor size, clinical T/N category, histology, and neoadjuvant treatment. Results: In total, 137 well-balanced pairs were obtained. There were no cases of 30-day mortality in the entire cohort. Conversion to thoracotomy was required more frequently in the VATS group (VATS 6.6% vs. robotic 0.7%, p=0.008). The complete resection rate (VATS 97.8% vs. robotic 98.5%, p=1.000) and postoperative complication rate (VATS 17.5% vs. robotic 19.0%, p=0.874) were not significantly different between the 2 groups. The robotic group showed a slightly shorter hospital stay (VATS 5.8±3.9 days vs. robotic 5.0±3.6 days, p=0.052). N2 nodal upstaging (cN0/pN2) was more common in the robotic group than the VATS group, but without statistical significance (VATS 4% vs. robotic 12%, p=0.077). Conclusion: Robotic anatomical resection in lung cancer showed comparable early outcomes when compared to VATS. In particular, robotic resection presented a lower conversion-to-thoracotomy rate. Furthermore, a robotic approach might improve lymph node harvesting in the N2 station.

• 경제분석
• /
• 제25권4호
• /
• pp.1-24
• /
• 2019

본 연구는 "대졸자직업이동경로조사"를 활용하여 학자금 대출 경험이 있는 대학 졸업자의 노동시장 성과에 대해 살펴보고 있다. 특히 분석대상을 대학 졸업 이후 18개월간 경험하는 모든 일자리로 확장하고, 대출 경험자의 이질성을 고려하기 위하여 성향점수 매칭 방법을 사용하였다. 분석의 주요 결과는 다음과 같다. 첫째, 학자금 대출 경험자는 대출 미경험자와 비교하여 첫 일자리의 임금이 2.81% 낮았다. 둘째, 첫 일자리에서 관찰된 임금격차는 시간이 흐르며 감소하였으며, 특히 이직 및 재취업으로 인해 0.66%p의 축소가 이루어졌다. 셋째, 졸업 후의 근로소득을 누적하여 비교하면 대출 경험자가 졸업 후 18개월까지 지속해서 높은 누적소득을 얻고 있었다. 이는 대출 경험자가 낮은 임금의 일자리라도 조기에 수락하기 때문에 미취업 상태로 지내는 기간은 짧고, 첫 취업 이후에는 더 높은 빈도로 이직과 재취업을 통해 임금을 높여가기 때문이다. 대출 경험자는 대출 경험이 없는 이들과 비교하여 이직 및 재취업 시 임금 상승분이 2.6만원 높았으며, 직장을 옮기는 횟수 또한 유의하게 많았다. 이상의 결과를 종합하면, 노동시장 진입 직후에 조사된 임금을 사용하여 수행된 이전의 연구 결과는 학자금 대출이 임금에 미치는 부정적 영향을 과대 추정할 수 있음을 의미한다. 하지만 고용의 질을 살펴보면 대출 경험자의 대기업 정규직 취업률은 지속적으로 낮았다. 초기 고용의 질이 장기적으로 임금 상승 및 일자리 안정성의 차이에 따른 생애소득의 격차로 이어질 수 있음을 고려하면 이는 향후 장기적인 관점에서 대출 경험자의 노동시장 성과를 검토할 필요가 있음을 시사한다.